-
23andMe’s GHR reports get first direct-to-consumer FDA authorization
SILVER SPRING, Md. — The Food and Drug Administration on Thursday allowed 23andMe to market its Personal Genome Service Genetic Health Risk tests for 10 diseases or conditions directly to consumers. The allowance makes 23andMe’s GHR the first direct-to-consumer test authorized that provides information about a patient’s genetic predisposition to diseases or medical conditions.
-
APhA, CDC team on fall risk training for pharmacists
WASHINGTON — The Centers for Disease Control and Prevention and the American Pharmacists Association have developed an online training tool on older adult fall prevention.
Called STEADI: The Pharmacist’s Role in Older Adult Fall Prevention, the free online training — based on the CDC’s Stopping Elderly Accidents, Deaths and Injuries initiative and accredited by the ACPE — was launched March 24 at the APhA Annual Meeting and Exposition in San Francisco.
